GE HealthCare beats, raises 2026 EPS guidance to $4.95–$5.05
GE HealthCare beats Q3 2026 estimates with adjusted EPS $1.34 on $5.5B revenue, raises 2026 EPS guidance to $4.95–$5.05
- Q3 2026 non-GAAP EPS $1.34 increased 25% year over year versus the prior-year quarter
- Q3 2026 revenue $5.5B grew between 7% and 7.2% year over year
- Company raised 2026 organic revenue growth and margin expansion targets alongside higher EPS guidance
- Board boosted the dividend 14% in conjunction with updated 2026 guidance and Q3 2026 results
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.